Parkinson's Disease (PD) Drugs Market Report

Global and China Parkinson's Disease (PD) Drugs Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 23, 2022
  • PAGES：167
  • REPORT CODE：GMM1401914
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Parkinson's Disease (PD) Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Biogen

    • Eli Lilly

    • Teva Pharmaceutical Industries

    • Otsuka Pharmaceutical

    • Pfizer

    • H Lundbeck

    • Novartis

    • Kyowa Hakko Kirin

    • Eisai

    • Addex Therapeutics

    • Boehringer Ingelheim

    • F Hoffmann-La Roche

    • AbbVie

    • Abital Pharma

    • GlaxoSmithKline

    • Impax Laboratories

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Dopamine Agonist

    • Monoamine Oxidase Inhibitors

    • Acetylcholinesterase Inhibitors

    • Glutamate Inhibitors

    Application:

    • Hospital

    • Family

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Parkinson's Disease (PD) Drugs Industry Overview

      • 1.1.1 Parkinson's Disease (PD) Drugs Market Scope and Market Segments

      • 1.1.2 Parkinson's Disease (PD) Drugs Industry Characteristics

      • 1.1.3 Global and China Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Parkinson's Disease (PD) Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Parkinson's Disease (PD) Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Dopamine Agonist

      • 1.2.2 Monoamine Oxidase Inhibitors

      • 1.2.3 Acetylcholinesterase Inhibitors

      • 1.2.4 Glutamate Inhibitors

    • 1.3 Global Parkinson's Disease (PD) Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Family

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Parkinson's Disease (PD) Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Parkinson's Disease (PD) Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Parkinson's Disease (PD) Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Parkinson's Disease (PD) Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Parkinson's Disease (PD) Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Parkinson's Disease (PD) Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Parkinson's Disease (PD) Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Parkinson's Disease (PD) Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Parkinson's Disease (PD) Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Parkinson's Disease (PD) Drugs Industry PEST Analysis

    • 2.3 Parkinson's Disease (PD) Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Parkinson's Disease (PD) Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Parkinson's Disease (PD) Drugs Industry

    Chapter 3 Global and China Parkinson's Disease (PD) Drugs Market, by Manufacturer

    • 3.1 Global and China Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Parkinson's Disease (PD) Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Parkinson's Disease (PD) Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Parkinson's Disease (PD) Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Parkinson's Disease (PD) Drugs Market Top 3 Players

    Chapter 4 Global and China Parkinson's Disease (PD) Drugs Market, by Type (2017-2028)

    • 4.1 Parkinson's Disease (PD) Drugs Market Trend, by Type

    • 4.2 Global Parkinson's Disease (PD) Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Parkinson's Disease (PD) Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Parkinson's Disease (PD) Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Parkinson's Disease (PD) Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Parkinson's Disease (PD) Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Parkinson's Disease (PD) Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Parkinson's Disease (PD) Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Parkinson's Disease (PD) Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Parkinson's Disease (PD) Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Parkinson's Disease (PD) Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Parkinson's Disease (PD) Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Parkinson's Disease (PD) Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Parkinson's Disease (PD) Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Parkinson's Disease (PD) Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Parkinson's Disease (PD) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Parkinson's Disease (PD) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Parkinson's Disease (PD) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Parkinson's Disease (PD) Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Parkinson's Disease (PD) Drugs Market Analysis

    • 7.1 North America Parkinson's Disease (PD) Drugs Market, by Type

    • 7.2 North America Parkinson's Disease (PD) Drugs Market, by Application

    • 7.3 North America Parkinson's Disease (PD) Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Parkinson's Disease (PD) Drugs Market Analysis

    • 8.1 Europe Parkinson's Disease (PD) Drugs Market, by Type

    • 8.2 Europe Parkinson's Disease (PD) Drugs Market, by Application

    • 8.3 Europe Parkinson's Disease (PD) Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Parkinson's Disease (PD) Drugs Market Analysis

    • 9.1 APAC Parkinson's Disease (PD) Drugs Market, by Type

    • 9.2 APAC Parkinson's Disease (PD) Drugs Market, by Application

    • 9.3 APAC Parkinson's Disease (PD) Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Parkinson's Disease (PD) Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Parkinson's Disease (PD) Drugs Company Profiles

      • 11.1 Biogen

        • 11.1.1 Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Biogen Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.1.3 Biogen Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Eli Lilly

        • 11.2.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Eli Lilly Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.2.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Teva Pharmaceutical Industries

        • 11.3.1 Teva Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.3.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Otsuka Pharmaceutical

        • 11.4.1 Otsuka Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.4.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Pfizer

        • 11.5.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Pfizer Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.5.3 Pfizer Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 H Lundbeck

        • 11.6.1 H Lundbeck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 H Lundbeck Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.6.3 H Lundbeck Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Novartis

        • 11.7.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Novartis Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.7.3 Novartis Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Kyowa Hakko Kirin

        • 11.8.1 Kyowa Hakko Kirin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.8.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Eisai

        • 11.9.1 Eisai Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Eisai Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.9.3 Eisai Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Addex Therapeutics

        • 11.10.1 Addex Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Addex Therapeutics Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.10.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Boehringer Ingelheim

        • 11.11.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.11.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 F Hoffmann-La Roche

        • 11.12.1 F Hoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 F Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.12.3 F Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 AbbVie

        • 11.13.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 AbbVie Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.13.3 AbbVie Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Abital Pharma

        • 11.14.1 Abital Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Abital Pharma Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.14.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 GlaxoSmithKline

        • 11.15.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 GlaxoSmithKline Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.15.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Impax Laboratories

        • 11.16.1 Impax Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Impax Laboratories Parkinson's Disease (PD) Drugs Product Profiles, Application and Specification

        • 11.16.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Parkinson's Disease (PD) Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Parkinson's Disease (PD) Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Parkinson's Disease (PD) Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease (PD) Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease (PD) Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease (PD) Drugs Market Size and Growth Rate of Dopamine Agonist (2017-2028)

    • Figure Global Parkinson's Disease (PD) Drugs Market Size and Growth Rate of Monoamine Oxidase Inhibitors (2017-2028)

    • Figure Global Parkinson's Disease (PD) Drugs Market Size and Growth Rate of Acetylcholinesterase Inhibitors (2017-2028)

    • Figure Global Parkinson's Disease (PD) Drugs Market Size and Growth Rate of Glutamate Inhibitors (2017-2028)

    • Figure Global Parkinson's Disease (PD) Drugs Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Parkinson's Disease (PD) Drugs Market Size and Growth Rate of Family (2017-2028)

    • Figure North America Parkinson's Disease (PD) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Parkinson's Disease (PD) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Parkinson's Disease (PD) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease (PD) Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Parkinson's Disease (PD) Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Parkinson's Disease (PD) Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Parkinson's Disease (PD) Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Parkinson's Disease (PD) Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Parkinson's Disease (PD) Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Parkinson's Disease (PD) Drugs Market Share, by Manufacturer in 2022

    • Table Global Parkinson's Disease (PD) Drugs Sales Volume, by Type (2017-2028)

    • Table Global Parkinson's Disease (PD) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Parkinson's Disease (PD) Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Parkinson's Disease (PD) Drugs Sales Value, by Type (2017-2028)

    • Table Global Parkinson's Disease (PD) Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Parkinson's Disease (PD) Drugs Price Trend, by Type (2017-2028)

    • Table China Parkinson's Disease (PD) Drugs Sales Volume, by Type (2017-2028)

    • Table China Parkinson's Disease (PD) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Parkinson's Disease (PD) Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Parkinson's Disease (PD) Drugs Sales Value, by Type (2017-2028)

    • Table China Parkinson's Disease (PD) Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Parkinson's Disease (PD) Drugs Price Trend, by Type (2017-2028)

    • Table Global Parkinson's Disease (PD) Drugs Sales Volume, by Application (2017-2028)

    • Table Global Parkinson's Disease (PD) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Parkinson's Disease (PD) Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Parkinson's Disease (PD) Drugs Sales Value, by Application (2017-2028)

    • Table Global Parkinson's Disease (PD) Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Parkinson's Disease (PD) Drugs Sales Value Share, by Application (2017-2028)

    • Table China Parkinson's Disease (PD) Drugs Sales Volume, by Application (2017-2028)

    • Table China Parkinson's Disease (PD) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson's Disease (PD) Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Parkinson's Disease (PD) Drugs Sales Value, by Application (2017-2028)

    • Table China Parkinson's Disease (PD) Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson's Disease (PD) Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson's Disease (PD) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Parkinson's Disease (PD) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Parkinson's Disease (PD) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Parkinson's Disease (PD) Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Parkinson's Disease (PD) Drugs Sales Volume, by Type (2017-2028)

    • Table North America Parkinson's Disease (PD) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Parkinson's Disease (PD) Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Parkinson's Disease (PD) Drugs Sales Volume, by Application (2017-2028)

    • Table North America Parkinson's Disease (PD) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Parkinson's Disease (PD) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Parkinson's Disease (PD) Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Parkinson's Disease (PD) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Parkinson's Disease (PD) Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Parkinson's Disease (PD) Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Parkinson's Disease (PD) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Parkinson's Disease (PD) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Parkinson's Disease (PD) Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Parkinson's Disease (PD) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Parkinson's Disease (PD) Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Parkinson's Disease (PD) Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Parkinson's Disease (PD) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Parkinson's Disease (PD) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease (PD) Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Parkinson's Disease (PD) Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Parkinson's Disease (PD) Drugs Sales Value and Growth Rate (2017-2028)

    • Table Biogen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biogen Product Profiles, Application and Specification

    • Table Biogen Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceutical Industries Product Profiles, Application and Specification

    • Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Otsuka Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Otsuka Pharmaceutical Product Profiles, Application and Specification

    • Table Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table H Lundbeck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table H Lundbeck Product Profiles, Application and Specification

    • Table H Lundbeck Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kyowa Hakko Kirin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kyowa Hakko Kirin Product Profiles, Application and Specification

    • Table Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eisai Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eisai Product Profiles, Application and Specification

    • Table Eisai Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Addex Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Addex Therapeutics Product Profiles, Application and Specification

    • Table Addex Therapeutics Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim Product Profiles, Application and Specification

    • Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table F Hoffmann-La Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table F Hoffmann-La Roche Product Profiles, Application and Specification

    • Table F Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie Product Profiles, Application and Specification

    • Table AbbVie Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abital Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abital Pharma Product Profiles, Application and Specification

    • Table Abital Pharma Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Impax Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Impax Laboratories Product Profiles, Application and Specification

    • Table Impax Laboratories Parkinson's Disease (PD) Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US